Svas Biosana Past Earnings Performance
Past criteria checks 3/6
Svas Biosana has been growing earnings at an average annual rate of 42.8%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 27.4% per year. Svas Biosana's return on equity is 7.3%, and it has net margins of 3.7%.
Key information
42.8%
Earnings growth rate
-2.1%
EPS growth rate
Medical Equipment Industry Growth | 8.3% |
Revenue growth rate | 27.4% |
Return on equity | 7.3% |
Net Margin | 3.7% |
Last Earnings Update | 30 Jun 2023 |
Revenue & Expenses BreakdownBeta
How Svas Biosana makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 23 | 112 | 4 | 15 | 0 |
31 Mar 23 | 106 | 4 | 14 | 0 |
31 Dec 22 | 100 | 4 | 14 | 0 |
30 Sep 22 | 94 | 3 | 13 | 0 |
30 Jun 22 | 88 | 3 | 12 | 0 |
31 Mar 22 | 85 | 3 | 11 | 0 |
31 Dec 21 | 82 | 3 | 11 | 0 |
30 Sep 21 | 80 | 3 | 15 | 0 |
30 Jun 21 | 79 | 3 | 19 | 0 |
31 Mar 21 | 78 | 3 | 15 | 0 |
31 Dec 20 | 77 | 3 | 12 | 0 |
Quality Earnings: SVS has high quality earnings.
Growing Profit Margin: SVS's current net profit margins (3.7%) are higher than last year (3.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if SVS's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare SVS's past year earnings growth to its 5-year average.
Earnings vs Industry: SVS earnings growth over the past year (42.8%) exceeded the Medical Equipment industry -18.4%.
Return on Equity
High ROE: SVS's Return on Equity (7.3%) is considered low.